Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A stochastic block prior for clustering in graphical models.

Psychological methods·2026
Same author

Progressive reduction in complications of cryoballoon pulmonary vein isolation for atrial fibrillation.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Phenotypic Refinement of ESAM-Related Tight-Junctionopathy: Novel Genetic and Ocular Findings and Literature Review.

Molecular genetics & genomic medicine·2026
Same author

Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review.

Movement disorders clinical practice·2026
Same author

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

NPJ Parkinson's disease·2026
Same author

<i>KIF5C</i>-Related Neurodevelopmental Disorder: Three New Cases and Additional Neuroradiologic Insights.

Neurology. Genetics·2026
Same journal

Levodopa responsive childhood-onset generalized dystonia with diaphragmatic involvement associated with an SPTBN2 variant.

Parkinsonism & related disorders·2026
Same journal

Approach to a case of Neuro-Gonadal disorder: Perrault syndrome.

Parkinsonism & related disorders·2026
Same journal

Parakinesia in Chorea: Why attribution of intention is misleading.

Parkinsonism & related disorders·2026
Same journal

Parkinson's disease risk in patients with ocular motor cranial neuropathy: a Korean population-based study.

Parkinsonism & related disorders·2026
Same journal

Target, dose and spacing in network-guided intermittent theta burst stimulation for Parkinson's disease.

Parkinsonism & related disorders·2026
Same journal

Loneliness and mood symptoms in Parkinson's disease: An item-level network analysis.

Parkinsonism & related disorders·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Molecular pathways in sporadic PD.

Enza Maria Valente1, Giuseppe Arena, Liliana Torosantucci

  • 1Neurogenetics Unit, CSS-Mendel Institute, Rome, Italy.

Parkinsonism & Related Disorders
|December 15, 2011
PubMed
Summary
This summary is machine-generated.

Identifying Parkinson's disease (PD) genes reveals cellular pathways like oxidative stress and impaired clearance systems. These insights into genetic and environmental factors are crucial for understanding both inherited and sporadic forms of PD.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Related Experiment Videos

Last Updated: May 26, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Numerous genes causing autosomal dominant and recessive Parkinson's disease (PD) have been identified over the past decade.
  • Functional studies of these genes' protein products and mutation effects illuminate cellular pathways involved in neurodegeneration, including oxidative stress, mitochondrial dysfunction, protein misfolding, and impaired cellular clearance systems (ubiquitin-proteasome system and autophagy).

Purpose of the Study:

  • To explore the pathogenetic mechanisms underlying Parkinson's disease (PD).
  • To investigate the role of identified genetic and environmental factors in both mendelian and sporadic forms of PD.
  • To identify critical molecular pathways contributing to neurodegeneration in PD.

Main Methods:

  • Review of identified autosomal dominant and recessive genes causative of PD.
  • Analysis of functional studies on protein products and pathogenetic effects of mutations.
  • Examination of cellular pathways implicated in neurodegeneration.
  • Consideration of genetic and environmental interactions in multifactorial disorder models.
  • Integration of findings from genome-wide association studies.

Main Results:

  • Identified genes and their functional studies reveal key neurodegenerative pathways in PD.
  • Mendelian PD genes provide insights applicable to sporadic PD, a multifactorial disorder.
  • Genetic and environmental factors interact, influencing disease onset.
  • Alpha-synuclein gene mutations cause dominant PD, while common variants associate with sporadic PD risk.

Conclusions:

  • Understanding mendelian PD genes and pathways offers a framework for investigating sporadic PD.
  • The multifactorial model highlights the interplay of genetic and environmental factors in PD pathogenesis.
  • Research on genes like alpha-synuclein opens new avenues for identifying critical neurodegenerative pathways.